BioPlus Acquisition Corp.

BioPlus Acquisition Corp. (ticker: BIOS) is a blank check company formed to pursue a business combination in the healthcare and life sciences sector. The company completed its initial public offering in 2021 and remained an active reporting entity as of its 10-Q quarterly report filed with the Securities and Exchange Commission on August 10, 2022 (accession no. 0001193125-22-217405). Healthcare-focused SPACs were among the most active deal categories during the 2020–2022 blank check cycle, as sponsors sought to channel capital into biopharma, medical technology, and adjacent subsectors. For complete filing history, deal timelines, sponsor details, and comparable SPAC analytics on BIOS, sign up for full data on SpacDesk.